InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,060.72
(
-1.08%
)
US TECH 100
17,103.80
(
-1.19%
)
Dow Jones
37,928.39
(
-1.19%
)
Brent Oil
86.00
(
-1.48%
)
Bitcoin
59,977.60
(
-6.05%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12424
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: trading_cyclist post# 57459

Tuesday, 12/16/2014 9:38:27 PM

Tuesday, December 16, 2014 9:38:27 PM

Post# of 80490
Please remember, the '113 trial will not be FULLY enrolled until Q3 2015, and we all know the FDA will insist that Ariad accomplish full enrollment due to Ariad's sordid past. THEN, Ariad HAS to file a NDA for approval. The FDA will take AT LEAST 6 months for review and possible early approval, so, the absolute earliest date for approval would be Q2 or Q3 2016. That is the facts..
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up